Source: ERJ Open Res, 4 (2) 00046-2018; 10.1183/23120541.00046-2018
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Christopher C. Butler, Samuel Coenen, Benjamin R. Saville, Johanna Cook, Alike van der Velden, Jane Homes, Menno de Jong, Paul Little, Herman Goossens, Philippe Beutels, Margareta Ieven, Nick Francis, Pieter Moons, Emily Bongard, Theo Verheij. A trial like ALIC⁴E: why design a platform, response-adaptive, open, randomised controlled trial of antivirals for influenza-like illness?. ERJ Open Res, 4 (2) 00046-2018; 10.1183/23120541.00046-2018

Member's Comments

No comment yet.

Related content which might interest you: Efficacy and costs of telehealth for the management of COPD: PROMETE II, a multicentre, randomized controlled trial Source: International Congress 2017 – New trends in pulmonary rehabilitation and chronic care Year: 2017 Late Breaking Abstract - Direct antivirals working against the novel coronavirus: azithromycin (DAWn-AZITHRO), a randomized, multicenter, open-label, adaptive, proof of concept clinical trial Source: Virtual Congress 2021 – Highlights in COVID-19 diagnosis and treatment Year: 2021 Cost-effectiveness of self-management in asthmatics: a 1-yr follow-up randomized, controlled trial Source: Eur Respir J 2001; 17: 206-213 Year: 2001 No gender-related bias in COPD diagnosis and treatment in Sweden: a randomised, controlled, case-based trial Source: ERJ Open Res, 6 (4) 00342-2020; 10.1183/23120541.00342-2020 Year: 2020 Clinical effect on uncontrolled asthma using a novel digital automated self-management solution: a physician-blinded randomised controlled crossover trial Source: Eur Respir J, 54 (5) 1900983; 10.1183/13993003.00983-2019 Year: 2019 Azithromycin for treatment of hospitalised COVID-19 patients: a randomised, multicentre, open-label clinical trial (DAWn-AZITHRO) Source: ERJ Open Res, 8 (1) 00610-2021; 10.1183/23120541.00610-2021 Year: 2022 RCT Abstract - Using a smartphone application in COPD patients to increase physical activity following pulmonary rehabilitation. Results of the AMOPUR Study, a multicenter, randomized, controlled study Source: Virtual Congress 2021 – A multidisciplinary approach to the management of chronic respiratory diseases Year: 2021 Effect of reflexology, homeopathy, and traditional medical treatment in asthma: A randomised, controlled, parallel-group trial Source: Annual Congress 2010 - Questionnaires use and psychological aspects in asthma Year: 2010 Late Breaking Abstract - A randomised, double-blind, placebo controlled, clinical trial evaluating imatinib in patients with severe COVID-19 Source: Virtual Congress 2021 – Late breaking basic and translational science of SARS-Cov2 and COVID-19 Year: 2021 RCT Abstract - Randomized, double-blind, placebo-controlled, phase III clinical trial with MV130, a sublingual bacterial immunotherapy to prevent COPD exacerbations Source: Virtual Congress 2021 – ALERT: COPD Year: 2021 Working memory training efficacy in COPD: the randomised, double-blind, placebo-controlled Cogtrain trial Source: ERJ Open Res, 7 (4) 00475-2021; 10.1183/23120541.00475-2021 Year: 2021 myAirCoach: mHealth assisted self-management in patients with uncontrolled asthma, a randomized control trial. Source: International Congress 2019 – M-health/e-health II Year: 2019 Clinical effect on asthma control using a novel digital self-management solution: a physician blinded randomized controlled crossover trial Source: International Congress 2019 – Medical education to improve practice Year: 2019 Multidimensional assessment and targeted therapy of severe asthma: a randomised controlled trial (RCT) Source: International Congress 2017 – Many faces of asthma assessment Year: 2017 Effectiveness of a pharmacist intervention for asthma control improvement: randomised controlled trial Source: Annual Congress 2007 - Delivering respiratory care: the challenges for primary care Year: 2007 Medical quality control intervention for COPD patients in China: a cluster randomized, controlled trial Source: Virtual Congress 2020 – Pharmacological management of COPD Year: 2020 Evaluation of ICS/LABA combination therapy on respiratory function in patients with asthma: Open-label, randomized, cross-over trial. Source: International Congress 2018 – New developments in the treatment of asthma Year: 2018 Effectiveness of influenza vaccination in asthmatic children: randomised, double-blind, placebo-controlled trial Source: Eur Respir J 2002; 20: Suppl. 38, 146s Year: 2002